PRDO Stock Analysis: Perdoceo Education | NASDAQ

Education & Training Services | NASDAQ, USA | Market Cap: 2.077m USD | 12M Return: 0.8% | US71363P1066 | Charts, Fundamentals & Technical Analysis

Online Learning, Health Sciences, Nursing Programs, Business Degrees
Total Rating 49
Safety 79
Buy Signal -0.28
Education & Training Services
Industry Rotation: -10.1
Market Cap: 2.08B
Avg Turnover: 18.8M
Risk 3d forecast
Volatility32.0%
VaR 5th Pctl4.91%
VaR vs Median-5.23%
Reward TTM
Sharpe Ratio0.08
Rel. Str. IBD32.9
Rel. Str. Peer Group46.4
Character TTM
Beta0.027
Beta Downside0.131
Hurst Exponent0.442
Drawdowns 3y
Max DD27.22%
CAGR/Max DD1.05
CAGR/Mean DD3.43
EPS (Earnings per Share) EPS (Earnings per Share) of PRDO over the last years for every Quarter: "2021-09": 0.45, "2021-12": 0.4, "2022-03": 0.5, "2022-06": 0.42, "2022-09": 0.39, "2022-12": 0.31, "2023-03": 0.58, "2023-06": 0.61, "2023-09": 0.64, "2023-12": 0.27, "2024-03": 0.6, "2024-06": 0.6, "2024-09": 0.59, "2024-12": 0.5, "2025-03": 0.7, "2025-06": 0.67, "2025-09": 0.65, "2025-12": 0.59, "2026-03": 0.9, "2026-06": 0.8,
EPS CAGR: 13.47%
EPS Trend: 93.9%
Last SUE: 0.00
Qual. Beats: 0
Revenue Revenue of PRDO over the last years for every Quarter: 2021-09: 173.998, 2021-12: 159.859, 2022-03: 182.959, 2022-06: 167.684, 2022-09: 168.42, 2022-12: 176.145, 2023-03: 195.598, 2023-06: 186.564, 2023-09: 179.923, 2023-12: 147.919, 2024-03: 168.264, 2024-06: 166.74, 2024-09: 169.828, 2024-12: 176.431, 2025-03: 213.004, 2025-06: 209.581, 2025-09: 211.872, 2025-12: 211.639, 2026-03: 221.743, 2026-06: 213.355,
Rev. CAGR: 9.36%
Rev. Trend: 79.5%
Last SUE: 0.19
Qual. Beats: 0

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Seasonality 11.6 years of data

Jan -0.1% 2
Feb -2.9% 20
Mar -0.1% 7
Apr +0.4% 17
May +7.0% 29
Jun -0.1% 7
Jul +0.0% 7
Aug -1.1% 2
Sep -0.9% 25
Oct +0.6% 16
Nov +8.9% 13
Dec -0.9% 13

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: PRDO Perdoceo Education

Perdoceo Education Corporation (NASDAQ: PRDO) is a U.S.-based provider of postsecondary education operating through three segments: Colorado Technical University (CTU), the American InterContinental University System (AIUS), and the University of St. Augustine for Health Sciences (USAHS). Programs are delivered online, on campus, and through blended formats, covering career-oriented fields such as business, nursing, healthcare management, IT, cybersecurity, criminal justice, and graduate-level health sciences degrees including physical and occupational therapy. The company also offers professional development and non-degree programs and supports its instruction with proprietary technology, including its intellipath learning platform and a mobile application with two-way messaging.

Formerly known as Career Education Corporation, Perdoceo rebranded in January 2020 and is headquartered in Schaumburg, Illinois. It trades on NASDAQ as a mid-cap stock classified within the Consumer Discretionary sector under Education Services.

As a participant in the for-profit postsecondary education industry, the companys revenue model is closely tied to student enrollment and tuition, with federal student aid programs such as Title IV typically representing a significant share of funding across the sector. Operators in this space are also subject to ongoing regulatory oversight, including rules related to program outcomes and borrower protections.

Headlines to Watch Out For
  • USAHS health sciences enrollment drives consolidated revenue growth
  • Title IV regulations and gainful employment rules pressure for-profit college margins
  • Aggressive share repurchases and dividends boost capital returns
Piotroski VR-10 (Strict) 6.5
Net Income: 177.1m TTM > 0 and > 6% of Revenue
FCF/TA: 0.16 > 0.02 and ΔFCF/TA 0.47 > 1.0
NWC/Revenue: 73.56% < 20% (prev 71.85%; Δ 1.71% < -1%)
CFO/TA 0.17 > 3% & CFO 225.4m > Net Income 177.1m
Net Debt (-1.30b) to EBITDA (275.4m): -4.71 < 3
Current Ratio: 4.69 > 1.5 & < 3
Outstanding Shares: last quarter (63.6m) vs 12m ago -4.91% < -2%
Gross Margin: 71.15% > 18% (prev 78.89%; Δ -7.74% > 0.5%)
Asset Turnover: 65.32% > 50% (prev 59.40%; Δ 5.92% > 0%)
Interest Coverage Ratio: 38.29 > 6 (EBIT TTM 237.0m / Interest Expense TTM 6.19m)
Altman Z'' 9.88
A: 0.47 (Total Current Assets 802.6m - Total Current Liabilities 171.1m) / Total Assets 1.33b
B: 0.60 (Retained Earnings 801.0m / Total Assets 1.33b)
C: 0.18 (EBIT TTM 237.0m / Avg Total Assets 1.31b)
D: 3.43 (Book Value of Equity 1.03b / Total Liabilities 301.1m)
Altman-Z'' = 9.88 = AAA
Beneish M -2.91
DSRI: 0.98 (Receivables 46.5m/42.4m, Revenue 858.6m/768.8m)
GMI: 1.11 (GM 78.89% / 71.15%)
AQI: 0.92 (AQ_t 0.30 / AQ_t-1 0.33)
SGI: 1.12 (Revenue 858.6m / 768.8m)
TATA: -0.04 (NI 177.1m - CFO 225.4m) / TA 1.33b)
Beneish M = -2.91 (Cap -4..+1) = A
What is the price of PRDO shares?

As of September 09, 2026, the stock is trading at USD 33.09 with a total of 527,825 shares traded. Over the past week, the price has changed by +0.06%, over one month by +5.82%, over three months by -2.41% and over the past year by +0.77%.

Current recommended Stop Loss: 31.60 (which is 4.5% or 1.3 ATR below the current price).

Is PRDO a buy, sell or hold?

Perdoceo Education has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy PRDO.

  • StrongBuy: 0
  • Buy: 1
  • Hold: 0
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the PRDO price?
Analysts Target Price 44 33%
Perdoceo Education (PRDO) - Fundamental Data Overview as of 06 September 2026
Market Cap USD = 2.08b (2.08b USD * 1.0 USD.USD)
P/E Trailing = 12.0691
P/E Forward = 10.0
P/S = 2.4197
P/B = 1.9977
P/EG = 0.6665
Revenue TTM = 858.6m USD
EBIT TTM = 237.0m USD
EBITDA TTM = 275.4m USD
Long Term Debt = 42.4m USD (estimated: total debt 56.6m - short term 14.2m)
Short Term Debt = 14.2m USD (from shortTermDebt, last quarter)
Debt = 170.4m USD (from shortLongTermDebtTotal, last quarter) + Leases 113.8m
Net Debt = -1.30b USD (calculated: Debt 170.4m - CCE 1.47b)
Enterprise Value = 778.5m USD (2.08b + Debt 170.4m - CCE 1.47b)
Interest Coverage Ratio = 38.29 (Ebit TTM 237.0m / Interest Expense TTM 6.19m)
EV/FCF = 3.57x (Enterprise Value 778.5m / FCF TTM 218.0m)
FCF Yield = 28.00% (FCF TTM 218.0m / Enterprise Value 778.5m)
FCF Margin = 25.39% (FCF TTM 218.0m / Revenue TTM 858.6m)
Net Margin = 20.63% (Net Income TTM 177.1m / Revenue TTM 858.6m)
Gross Margin = 71.15% ((Revenue TTM 858.6m - Cost of Revenue TTM 247.7m) / Revenue TTM)
Gross Margin QoQ = 76.15% (prev 74.56%)
Tobins Q-Ratio = 0.58 (Enterprise Value 778.5m / Total Assets 1.33b)
Interest Expense / Debt = 3.63% (Interest Expense 6.19m / Debt 170.4m)
Taxrate = 23.80% (55.3m / 232.4m)
NOPAT = 180.6m (EBIT 237.0m * (1 - 23.80%))
Current Ratio = 4.69 (Total Current Assets 802.6m / Total Current Liabilities 171.1m)
Debt / Equity = 0.16 (Debt 170.4m / totalStockholderEquity, last quarter 1.03b)
Debt / EBITDA = -4.71 (Net Debt -1.30b / EBITDA 275.4m)
Debt / FCF = -5.96 (Net Debt -1.30b / FCF TTM 218.0m)
Total Stockholder Equity = 1.00b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.47% (Net Income 177.1m / Total Assets 1.33b)
RoE = 17.70% (Net Income TTM 177.1m / Total Stockholder Equity 1.00b)
RoCE = 22.72% (EBIT 237.0m / Capital Employed (Equity 1.00b + L.T.Debt 42.4m))
RoIC = 15.92% (NOPAT 180.6m / Invested Capital 1.13b)
WACC = 5.83% (E(2.08b)/V(2.25b) * Re(6.08%) + D(170.4m)/V(2.25b) * Rd(3.63%) * (1-Tc(0.24)))
Discount Rate = 6.08% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -85.75 | Cagr: -2.19%
[DCF] Terminal Value 76.21% ; FCFF base≈212.9m ; Y1≈224.7m ; Y5≈262.8m
[DCF] Fair Price = 85.41 (EV 4.05b - Net Debt -1.30b = Equity 5.34b / Shares 62.6m; r=8.35% [WACC [floored]]; 5y FCF grow 6.13% → 2.50% )
EPS Correlation: 93.93 | EPS CAGR: 13.47% | SUE: 0.0 | # QB: 0
Revenue Correlation: 79.49 | Revenue CAGR: 9.36% | SUE: 0.19 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.74 | Chg30d=+0.00% | Revisions=-25% | Analysts=1
EPS current Year (2026-12-31): EPS=3.13 | Chg30d=+0.64% | Revisions=+25% | GrowthEPS=+19.9% | GrowthRev=+1.0%
EPS next Year (2027-12-31): EPS=3.30 | Chg30d=-1.20% | Revisions=+25% | GrowthEPS=+5.4% | GrowthRev=+3.0%